Brokerages Set Aspen Aerogels, Inc. (NYSE:ASPN) PT at $30.75

Shares of Aspen Aerogels, Inc. (NYSE:ASPN) have received a consensus rating of “Buy” from the eight brokerages that are presently covering the stock, Marketbeat Ratings reports. Seven equities research analysts have rated the stock with a buy recommendation and one has given a strong buy recommendation to the company. The average 12 month price objective among brokerages that have issued ratings on the stock in the last year is $30.75.

A number of equities analysts recently commented on ASPN shares. TD Cowen lifted their price target on Aspen Aerogels from $30.00 to $36.00 and gave the stock a “buy” rating in a report on Wednesday, June 5th. B. Riley upgraded Aspen Aerogels to a “strong-buy” rating in a report on Tuesday, June 25th. Piper Sandler boosted their price objective on Aspen Aerogels from $30.00 to $36.00 and gave the stock an “overweight” rating in a report on Wednesday, May 29th. Craig Hallum boosted their price objective on Aspen Aerogels from $33.00 to $38.00 and gave the stock a “buy” rating in a report on Friday, June 14th. Finally, Roth Mkm restated a “buy” rating and set a $36.00 price objective (up previously from $28.00) on shares of Aspen Aerogels in a report on Wednesday, June 12th.

Insider Buying and Selling

In related news, SVP Keith L. Schilling sold 20,000 shares of the business’s stock in a transaction on Monday, May 13th. The shares were sold at an average price of $26.84, for a total value of $536,800.00. Following the sale, the senior vice president now owns 28,792 shares of the company’s stock, valued at $772,777.28. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. In other Aspen Aerogels news, SVP Corby C. Whitaker sold 55,159 shares of the company’s stock in a transaction on Monday, May 6th. The shares were sold at an average price of $25.01, for a total transaction of $1,379,526.59. Following the sale, the senior vice president now owns 131,533 shares of the company’s stock, valued at $3,289,640.33. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, SVP Keith L. Schilling sold 20,000 shares of the company’s stock in a transaction on Monday, May 13th. The shares were sold at an average price of $26.84, for a total transaction of $536,800.00. Following the sale, the senior vice president now directly owns 28,792 shares in the company, valued at approximately $772,777.28. The disclosure for this sale can be found here. Insiders have sold a total of 3,832,103 shares of company stock valued at $91,679,369 over the last 90 days. 4.30% of the stock is owned by insiders.

Hedge Funds Weigh In On Aspen Aerogels

Several institutional investors have recently made changes to their positions in ASPN. Mesirow Institutional Investment Management Inc. acquired a new position in shares of Aspen Aerogels during the fourth quarter valued at about $12,015,000. Federated Hermes Inc. raised its holdings in shares of Aspen Aerogels by 53.9% in the 4th quarter. Federated Hermes Inc. now owns 1,154,042 shares of the construction company’s stock worth $18,211,000 after acquiring an additional 404,042 shares during the last quarter. Hood River Capital Management LLC raised its holdings in shares of Aspen Aerogels by 12.2% in the 1st quarter. Hood River Capital Management LLC now owns 3,300,443 shares of the construction company’s stock worth $58,088,000 after acquiring an additional 357,895 shares during the last quarter. Assenagon Asset Management S.A. raised its holdings in shares of Aspen Aerogels by 577.1% in the 2nd quarter. Assenagon Asset Management S.A. now owns 244,512 shares of the construction company’s stock worth $5,832,000 after acquiring an additional 208,398 shares during the last quarter. Finally, Vanguard Group Inc. raised its holdings in shares of Aspen Aerogels by 5.1% in the 1st quarter. Vanguard Group Inc. now owns 3,619,702 shares of the construction company’s stock worth $63,707,000 after acquiring an additional 175,906 shares during the last quarter. Institutional investors and hedge funds own 97.64% of the company’s stock.

Aspen Aerogels Trading Down 9.3 %

Aspen Aerogels stock opened at $18.88 on Monday. The firm has a 50-day moving average of $26.02 and a 200-day moving average of $20.33. Aspen Aerogels has a one year low of $5.32 and a one year high of $31.74. The company has a debt-to-equity ratio of 0.24, a current ratio of 4.01 and a quick ratio of 3.29. The company has a market cap of $1.44 billion, a price-to-earnings ratio of -42.91 and a beta of 2.15.

Aspen Aerogels (NYSE:ASPN) last posted its quarterly earnings data on Wednesday, May 1st. The construction company reported $0.01 EPS for the quarter, topping analysts’ consensus estimates of ($0.13) by $0.14. Aspen Aerogels had a negative net margin of 10.73% and a negative return on equity of 6.35%. The company had revenue of $94.50 million during the quarter, compared to the consensus estimate of $73.04 million. On average, equities analysts expect that Aspen Aerogels will post 0.18 earnings per share for the current fiscal year.

About Aspen Aerogels

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.